Global Adoption of Leadless Pacemakers – Market Growth Analysis
According to FutureWise analysis the market for leadless pacemakers in 2023 was US$ 260 million, and is expected to reach US$ 430 million by 2031 at a CAGR of 7.7%.
Pacemakers are essential devices that deliver small electrical pulses to the heart muscles to maintain a stable heart rate and stimulate the lower chambers of the heart. The implantation of leadless pacemakers is performed using a catheter, which is a long, thin tube. To begin the procedure, a catheter is inserted into the femoral vein through a small incision in the groin, an area that is numbed with local anesthesia to minimize discomfort. An X-ray machine assists the doctor in guiding the catheter to the heart. Once the catheter is in place, the pacemaker is positioned in the right ventricle, where it is tested to ensure proper installation and programming. After the procedure, the catheter is removed, and pressure is applied to the incision site to facilitate closure.
Every year, over one million cardiac pacemakers are implanted globally, with approximately 200,000 procedures occurring in the United States alone. This number is expected to grow due to the aging population and increasing prevalence of heart conditions. Since the first pacemaker was implanted in the 1950s, cardiac pacemaker technology has advanced considerably. Enhancements in battery life, lead quality, algorithmic programming, and rate responsiveness have transformed the implantation and management of transvenous cardiac pacemakers.Currently, two notable leadless pacing systems are available: the Nanostim Leadless Cardiac Pacemaker and the Medtronic Micra Transcatheter Pacing System. Both devices utilize a catheter delivery system inserted through the femoral vein, but they differ in size, heart fixation methods, and responsiveness features. These advancements in pacemaker technology continue to improve patient outcomes and device longevity.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=202%20&type=requestsample
Leadless Pacemakers Market Segmentation:
By Technology
- Micra Transcatheter Pacing System
- Nanostim Leadless Pacemakers
- Wireless Cardiac Simulation System
By Indication
- Atrial Fibrillation
- High Degree Atrioventricular Block
- Sinus node dysfunction
- Others
By End-user
- Hospitals
- ASCs
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Leadless Pacemakers Market:
- Medtronics
- St. Jude Medical LLC (Abbott Laboratories)
- Biotronic
- Boston Scientific
- Edwards Lifesciences
- Sorin Group
- Vitatron
- Lepu Medical
- Terumo Corp.
Ask For Discount: https://www.futurewiseresearch.com/checkout.aspx?ReportId=202&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Leadless Pacemakers Market By Technology, By Indication, By End user and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian